Author/Creator: Essner, Ute - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Essner, Ute

1. Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies. (March 2019)

Authors:: Akgün, Katja; Essner, Ute; Seydel, Cordula; Ziemssen, Tjalf
Journal:: Journal of central nervous system disease
Issue:: Volume 11(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry. Issue 4 (4th September 2021)

Authors:: Ueberall, Michael A; Vila Silván, Carlos; Essner, Ute; Mueller-Schwefe, Gerhard H H
Journal:: Pain medicine
Issue:: Volume 23:Issue 4(2022)
Page Start:: 745
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain. (3rd July 2022)

Authors:: Überall, Michael A.; Essner, Ute; Müller-Schwefe, Gerhard H. H.
Journal:: Current medical research and opinion
Issue:: Volume 38:Number 7(2022)
Page Start:: 1141
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials. Issue 4 (9th February 2021)

Authors:: Dykukha, Igor; Malessa, Rolf; Essner, Ute; Überall, Michael A
Journal:: Pain medicine
Issue:: Volume 22:Issue 4(2021)
Page Start:: 861
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry. (2nd January 2022)

Authors:: Ueberall, Michael A.; Essner, Ute; Müller-Schwefe, Gerhard; Horlemann, Johannes; Storr, Martin
Journal:: Current medical research and opinion
Issue:: Volume 38:Number 1(2022)
Page Start:: 101
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial. (1st February 2019)

Authors:: Markovà, Jolana; Essner, Ute; Akmaz, Bülent; Marinelli, Marcella; Trompke, Christiane; Lentschat, Arnd; Vila, Carlos
Journal:: International journal of neuroscience
Issue:: Volume 129:Number 2(2019)
Page Start:: 119
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial. (1st December 2020)

Authors:: Meuth, Sven G; Henze, Thomas; Essner, Ute; Trompke, Christiane; Vila Silván, Carlos
Journal:: International journal of neuroscience
Issue:: Volume 130:Number 12(2020)
Page Start:: 1199
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗